CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine (Merkel cell) carcinoma of the skin.

Cook, A L; Pollock, P M; Welch, J; Walsh, M D; Bowman, R V; Baumann, K C; Hayward, N K; Leonard, J H

Cook, A L; Pollock, P M; Welch, J; Walsh, M D; Bowman, R V; Baumann, K C; Hayward, N K; Leonard, J H.

Affiliation

Cook AL; Queensland Radium Institute Laboratory, Joint Experimental Oncology Program, Queensland Institute of Medical Research and the University of Queensland, Herston, Queensland, Australia.

Int J Cancer ; 93(3): 361-7, 2001 Aug 01.

Article in En | MEDLINE | ID: mdl-11433400

Subject(s)

Carcinoma, Merkel Cell/genetics; Chromosomes, Human, Pair 9/genetics; Cyclin-Dependent Kinase Inhibitor p16/genetics; Gene Deletion; Skin Neoplasms/genetics; Blotting, Western; Chromosome Aberrations; Cyclin-Dependent Kinase Inhibitor p16/metabolism; Heterozygote; Homozygote; Humans; Immunoenzyme Techniques; Loss of Heterozygosity; Microsatellite Repeats; Mutation; Proteins/genetics; Proteins/metabolism; Tumor Suppressor Protein p14ARF

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Chromosomes, Human, Pair 9 / Carcinoma, Merkel Cell / Gene Deletion / Cyclin-Dependent Kinase Inhibitor p16 Limits: Humans Language: En Journal: Int J Cancer Year: 2001 Document type: Article Affiliation country: Australia

Search on Google

Add to My VHL

XML

PubMed Links